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Overexpression of the Naþ/Ca2þ exchanger (NCX) in mammals is associated
with arrhythmias in cardiac hypertrophy and failure. The function and regulation
of NCX genes varies significantly among vertebrates likely reflecting differences
in molecular structure. We have previously reported that b-adrenergic suppres-
sion of the Ca2þ-efflux and -influx modes of amphibian cardiac NCX1.1 is asso-
ciated with specific molecular motifs. In contrast, cardiac NCX of shark (Squalus
acanthias) shows ‘bimodal’ adrenergic regulation with preferential suppression
of the Ca2þ-influx mode (Woo and Morad, PNAS 98:2023, 2001); and its se-
quence (DQ 068478) reveals two novel proline/alanine-rich AA-insertions.
Here we examined the effects of deleting the longer of these inserts.
Shark and mutant shark cardiac NCX were expressed in mammalian cells (HEK
293 and FlpIn 293), and their activity was measured as Ni2þ-sensitive Ca2þ-
fluxes (Fluo-4) and membrane currents (INaCa) by changing [Na
þ]o and/or mem-
brane potential (Vm). Bimodal regulation, defined as differential regulation of
Ca2þ-efflux and influx pathways with a strong suppression of its Ca2þ-influx
mode and no change, or enhancement, of the Ca2þ-efflux mode, persisted in
the shark NCX regardless of Ca2þ buffering, closely resembling the b-adrener-
gic regulation of native shark cardiomyocytes. In contrast, b-adrenergic stimu-
lation of the shark mutant NCX produced an equal suppression of the inward and
outward currents as well as the Ca2þ fluxes (as found with frog NCX), thereby
abolishing the bimodal nature of the regulation. Control experiments were car-
ried out with untransfected and dog cardiac NCX expressing cells.
We conclude that shark NCX is physiologically functional in mammalian cells,
retaining the essentials of its bimodal b-adrenergic regulation. In addition, the
deleted shark-specific insert was found to affect the modality of cAMP-depen-
dent regulation, possibly because it provides essential intramolecular flexibility
and/or binding sites.
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Calmidazolium Inhibits Naþ/ca2þ Antiporter In Mitochondria
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Amajor function of Ca2þ in mitochondria is the regulation of intramitochondrial
enzyme activity. A rise of Ca2þ in mitochondria can stimulate the oxidative me-
tabolism and ATP production through activating Ca25sensitive matrix dehydro-
genases and controlling the synthesis of ATP. The main mechanism of the Ca2þ
efflux from mitochondria in the cells of heart, brain, skeletal muscles, pancreas,
and the majority of tumor cells is the Naþ/Ca2þ exchange (NCXmito). Appli-
cation of the NCX inhibitors (tetraphenylphosphonium cation, CGP37157) in-
creases the concentration of Ca2þ ([Ca2þ]m) and NADH level in mitochondria,
and stimulates the oxidative metabolism. Little is known about the regulation of
NCXmito. In this work it is shown, that calmodulin (CaM) participates in the reg-
ulation of the antiporter activity. To study the NCXmito activity, we used the
Ca25signal generating purinoreceptors of Ehrlich ascites tumor cells (EATC)
and an inhibitor of CaM, R24571. R24571- and ATP-induced changes in the
[Ca2þ]i, [Ca2þ]m, NADH fluorescence, and the membrane potential of mito-
chondria were recorded. ATP produced a transitory increase in [Ca2þ]i,
[Ca2þ]m and NADH fluorescence. A preliminary addition of Naþ/Ca2þ ex-
change inhibitors slightly changed the cytosolic signal, but suppressed the efflux
of Ca2þ from mitochondria. Addition of ionomycin (0.5mM) in the time of the
plateau in the mitochondrial Ca25signal caused a decrease in Rhod-2 and
NADH fluorescence up to the initial level, which indicated the Ca25efflux
from mitochondria. R24571 (3-5mM) caused a transitory Ca25signal in the cy-
tosol and an irreversible increase of NADH and Rhod-2 fluorescence. Ionomycin
caused NADH and Rhod-2 fluorescence to recover to the initial level. Thus,
R24571 inhibits the NCXmito in EATC, which suggests that its activity is reg-
ulated by CaM.
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High-Yield Expression and Purification of a Plasma Membrane Citrate
Transport Protein
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RosalindFranklinUniversity ofMedicine andScience,NorthChicago, IL,USA.Citrate is prominently and uniquely involved in metabolic crossroads that gov-
ern the energy balance of human and other organisms, yet little is known about
the molecular mechanisms determining its entry into cells. The unique ability
of plasma membrane citrate transporters (PMCTs) to import extracellular cit-
rate into the cytoplasm confers upon them an essential role in determining an
organism’s energy state. Thus, PMCTs located in liver and brain figure prom-
inently in: i) fatty acid, lipid, and cholesterol biosyntheses; ii) control of glu-
cose metabolism via the citrate-mediated allosteric inhibition of PFK-1; and
iii) neuronal cell synthesis of neurotransmitters. Therefore, inhibition of hu-
man PMCT function may prove to be a novel strategy for altering energy bal-
ance in a manner that mimics caloric restriction. With this background in
mind, we recently cloned PMCTs from C. elegans, Drosophila, mouse, rat,
and human into the Pichia pastoris expression system and developed a biofer-
mentation protocol for high-yield expression of the human and the C. elegans
PMCTs. We have been able to successfully purify detergent-solubilized C. el-
egans PMCT via sequential chromatography on Ni-NTA, Talon, and Super-
dex, resulting in material that is > 90% pure. Mass spectrometry confirms
that full-length C. elegans PMCT was the purified entity. Preliminary studies
indicate that we have been able to successfully reconstitute detergent-solubi-
lized C. elegans PMCT function in liposomal vesicles. Sulfhydryl reagents
such as NEM and pCMB effectively inhibit the reconstituted transporter.
These studies provide the foundation for a detailed structure/function analysis
of this metabolically essential plasma membrane transport protein. Supported
by NIH grant GM-054642 to R.S.K.
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What are the structural determinants of Cr transport regulation?
Lucia K. Santacruz-Toloza, Marcus D. Darrabie, Rajashree Mishra, Danny
O. Jacobs.
Duke University Medical Center, Durham, NC, USA.
Phosphocreatine (PCr) and Creatine Cr play key roles in energy metabolism
by replenishing ATP levels via creatine kinases and ADP. The sole source of
Cr to skeletal and cardiac myocytes is transport by the Cr transporter (CrT),
a membrane protein belonging to the neurotransmitter transporter family
(SLC6) that also includes the serotonin, dopamine and norepinephrine trans-
porters. Previous work suggests that Cr transport is modulated by AMPK and
PKC. For example, Cr transport in HL-1 cardiomyocytes expressing the hu-
man CrT is decreased when the cells are treated with b-PMA, or incubated in
culture media enriched for Cr. Cr transport increases if these cells are incu-
bated in culture media depleted of Cr or supplemented with AICAR, an
AMPK activator. To identify phosphorylation sites that regulate CrT func-
tion, we created single and multiple site mutants lacking putative intracellular
phosphorylation sites that scored highly (greater than 0.7) when the trans-
porter protein sequence was evaluated by the NetPhos 2.0 algorithm (CBS,
Technical University of Denmark). These sites tended to cluster at the begin-
ning of the N-terminus and the end of the C-terminus of the protein. Ablation
of these potential phosphorylation sites had no effect on transport capacity, or
the ability to respond to b-PMA, AICAR or substrate availability. We also
generated mutants with incremental deletions of the N-or C-termini of the
CrT protein. Deletions that remove the entire N or C-terminus resulted in
the expression of an inactive transporter protein, while smaller truncations
yielded functional Cr transporters that still responded to PKC and AMPK
activation and Cr availability like the phosphorylation mutants. Therefore,
either low-probability phosphorylation site(s) modulate CrT activity
and/or a yet to be identified signalling molecule or interacting protein(s)
are responsible for modulation of Cr transport by AMPK, PKC and substrate
availability.
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What Localization Of UCP4 Can Tell Us About Its Function?
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UCP4 is a member of the mitochondrial uncoupling protein subfamily und is
suggested to be mainly involved regulation of reactive oxidative species and/
or calcium concentration. Here we investigate for the first time the subcellu-
lar, cellular and tissue distribution of UCP4 at physiological conditions using
antibodies against UCP4. Affinity purificated polyclonal anti-body against
UCP4 was first designed and evaluated using recombinant protein UCP4-
GFP. We present evidences that UCP4 is expressed in central nervous system,
as previously shown at mRNA level. The described distribution of UCP4
mRNA in kidney was not confirmed an the protein level. Protein are ex-
pressed in both fetal and adult murine brain tissue. UCP4 dis-tribution pattern
in neuronal cell bodies does not support the idea of thermogenesis in syn-ap-
ses. The hypothesis that proapoptotic stress may induce transient UCP4 ex-
pression as a component of an apoptotic pathway during neuronal differenti-
ation is discussed.
